Organophosphate pesticide exposure is not associated with autism-related traits through the prenatal or early childhood period of life.

Subcutaneous autoinjector formulation expands starting treatment options for mild cognitive impairment and mild dementia due to Alzheimer disease.

Small changes to night-shift hours appear to improve sleep quality and inflammatory biomarkers among emergency medicine physicians.

Patients with schizophrenia report that negative symptoms significantly impair work performance and interpersonal relationships.

Looming cognitive style directly affects anxiety, but influences depression through rumination among undergraduate students.

Only 3 of the 1357 FDA-authorized artificial intelligence medical devices have been evaluated for clinical effectiveness.

Severe mental illness is linked to a higher risk for premature death from physical illnesses like cardiovascular and respiratory diseases.

Early-life immune activation from bacterial or viral infections may increase the risk for psychiatric disorders in childhood and adolescence.

The FDA granted Priority Review to Teva's NDA for ecopipam, a selective D1 antagonist for pediatric Tourette syndrome.

Over two-thirds of patients report accessing test results through patient portals before hearing from providers.

Dr Erica Schwartz will lead the CDC following a recent confirmation vote in the Senate confirming her appointment as head of the agency.

Disparities in health care access may influence the likelihood of initiating antidepressant medications after COVID-19 exposure.